United States · Investor

Euclidean Capital

Last cheque observed Oct 2026; 11 cheques on record.

Deploying nowFamily office

BuyoutGrowthSeedFood And BeverageSocial ImpactSustainability

Deploying now
100%of best year3cheques in 12 months, 11 on record
Since the last cheque1days00hrs00min00sec
Median round$65MRounds led0 of 11Mostly inUnited States, 100%
Pitch Euclidean Capital

Euclidean Capital highlights

  1. 01

    3 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 50% of its rounds

What they do

Type
Family office (from a list, unverified)
Cheque size
Not stated
Stages
BuyoutGrowthSeedSeries ASeries B
Sectors
Food And BeverageSocial ImpactSustainability
Based in
Houma, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first11 appearances

  1. 2026

    2 rounds

  2. Oct
    Setara BiosciencesSeries A · US · Pulse 2.0$90MWith 6 others
  3. Sept
    Savvy WealthSeries C · US · Ventureburn$100MWith 9 others
  4. 2025

    3 rounds

  5. Dec
    Ripple FoodsUS · AlleyWatch$17MWith 9 others
  6. Aug
    SetPoint MedicalSeries D · US · Elevage Medical Technologies$140MWith 17 others
  7. Mar
    ZeitviewGrowth · US · Energy Transition Ventures$60MWith 9 others
  8. 2019

    3 rounds

  9. Nov
    PMV PharmaSeries C · US · Prweb$62MWith 7 others
  10. Nov
    BuildOPsSeed · US · TechCrunch$5.8MWith 12 others
  11. Oct
    ArsenalBioSeries A · US · FinSMEs$85MWith 6 others
  12. 2018

    3 rounds

  13. Dec
    KallyopeSeries B · US · FinSMEs$21MWith 6 others
  14. Feb
    KallyopeSeries B · US · FinSMEs$66MWith 6 others
  15. Jan
    Ribon TherapeuticsSeries B · US · Marketwatch$65MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

Legal name
Ardinall Investment Management LP
SEC number
CRD 298114

Who they invest alongside

The investors most often in the same rounds as Euclidean Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Euclidean Capital put money into.

Mentioned on podcasts

Episodes that name Euclidean Capital in their description, not their title.

Quick answers about Euclidean Capital

What does Euclidean Capital invest in?

Euclidean Capital invests most often at Series B and Series A (50% of the rounds on record), in sectors such as Food And Beverage, Social Impact and Sustainability.

How active is Euclidean Capital?

11 investments on record, 3 of them in the last 12 months. The most recent was in Oct 2026.

What has Euclidean Capital invested in recently?

Its most recent investments on record: Setara Biosciences (Series A, Oct 2026), Savvy Wealth (Series C, Sept 2026) and Ripple Foods (Dec 2025).

How big are Euclidean Capital's cheques?

The median round it joins is $65M.

Does Euclidean Capital lead rounds?

Rarely, if at all: none of its 11 investments on record names it as the lead.

Where does Euclidean Capital invest?

Most of the companies it backs are in the United States (100%).

Is Euclidean Capital investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

Who does Euclidean Capital invest alongside?

Most often Osage University Partners (3 rounds together), The Column Group (3 rounds together) and Alexandria Real Estate Equities (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it